Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects.
Wei W, Zeng Q, Wang Y, Guo X, Fan T, Li Y, Deng H, Zhao L, Zhang X, Liu Y, Shi Y, Zhu J, Ma X, Wang Y, Jiang J, Song D.
Wei W, et al.
Acta Pharm Sin B. 2023 May;13(5):2138-2151. doi: 10.1016/j.apsb.2022.12.009. Epub 2022 Dec 14.
Acta Pharm Sin B. 2023.
PMID: 37250154
Free PMC article.